Funding Round
Beacon Biosignals Raises $86M Series B for AI-Driven EEG Biomarkers
Beacon Biosignals11/13/2025·11/13/25🌐 USA
Summary
Beacon Biosignals raised $86M Series B for AI-driven neurodiagnostic dataset and EEG biomarker platform for brain health.
Why it matters
Beacon Biosignals' $86M Series B accelerates their AI-driven EEG biomarker platform, which reads brain signals to predict drug response and disease progression. Pharma partnerships make this a critical infrastructure play for CNS drug development rather than a direct-to-patient device.
#AI#AI Diagnostics#Biomarkers#EEG#Industry#Venture Capital
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in